HCA Healthcare Insider Jon Foster Sells $10.4 Million in Stock

As seen on the 24/7 Wall St. homepage on November 6, 2026.

Sold HCA Healthcare, Inc. $10.4M20,309 shares @ $510.7

An HCA executive converted stock appreciation rights at $145 and unloaded roughly $38 million of common stock near $500, leaving one tranche at zero shares held. Discretionary selling into a hospital group facing Medicaid cuts and a tougher 2027 Medicare outpatient rule is worth noting.

Continue ReadingShow less

On November 6, 2026, Jon M. Foster, an executive at HCA Healthcare, sold 20,309 shares of common stock, generating just over $10.4 million in proceeds.

The transaction was part of a broader sequence that also involved converting stock appreciation rights, with one tranche leaving Foster at zero shares held after the exercise. That combination in a single window tends to draw closer scrutiny from investors tracking insider sentiment.

Sponsored

HCA Healthcare is operating against a backdrop of Medicaid funding cuts and a tighter 2027 Medicare outpatient reimbursement rule, both of which carry direct implications for the hospital group's revenue outlook. Discretionary selling into that policy uncertainty is a signal long-term shareholders in the hospital sector tend to log carefully.

Insider sales alone do not indicate a change in company fundamentals, and executives sell shares for many personal financial reasons. Even so, the size of the total disposition and the zero-share outcome on one tranche make this a transaction worth tracking as clarity on the Medicare and Medicaid landscape develops into 2027.

Mentioned: HCA